TRPV1 Antagonists and Chronic Pain: Beyond Thermal Perception
In the last decade, considerable evidence as accumulated to support the development of Transient Receptor Potential Vanilloid 1 (TRPV1) antagonists for the treatment of various chronic pain conditions. Whereas there is a widely accepted rationale for the development of TRPV1 antagonists for the trea...
Saved in:
Main Authors: | Michael R. Brandt (Author), Chad E. Beyer (Author), Stephen M. Stahl (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2012-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Influence of TRPV1 on diabetes-induced alterations in thermal pain sensitivity
by: Pauza Mary E, et al.
Published: (2008) -
Discovery of Dual TRPA1 and TRPV1 Antagonists as Novel Therapeutic Agents for Pain
by: Nayeon Do, et al.
Published: (2024) -
Unveiling the mechanisms of neuropathic pain suppression: perineural resiniferatoxin targets Trpv1 and beyond
by: Safa Shehab, et al.
Published: (2023) -
K-685, a TRPV1 Antagonist, Blocks PKC-Sensitized TRPV1 Activation and Improves the Inflammatory Pain in a Rat Complete Freund's Adjuvant Model
by: Yoshiyuki Sugimoto, et al.
Published: (2013) -
Moving towards supraspinal TRPV1 receptors for chronic pain relief
by: Berrino Liberato, et al.
Published: (2010)